Apollo Medical Holdings, Inc.

AMEH F | $40.82 -0.81% 310K

(0.0% 1d) (0.0% 1m) (11.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (163.8% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 2,379,136,103
http://www.apollomed.net
Sec Filling | Patents | 555 employees

(US) Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient, and physician alignment solutions. The company focuses on physicians providing medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.

add to watch list Paper trade email alert is off

Syneos Health, Inc.

SYNH | $42.98 0.0% 7.4M

Health Services

(0.0% 1d) (0.0% 1m) (9.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (107.31% volume)
Earnings Calendar: 2023-11-02
Market Cap: $ 4,457,850,313
http://www.syneoshealth.com
Sec Filling | Patents | 24000 employees

(US) Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.

communication

add to watch list Paper trade email alert is off

National Research Corporation

NRC 4 | $34.22 1.57% 1.55% 74K

Health Services

(0.0% 1d) (-14.7% 1m) (-24.4% 1y) (0.0% 2d) (0.0% 3d) (1.1% 7d) (-41.98% volume)
Earnings Calendar:
Market Cap: $ 816,884,201
http://www.nrchealth.com
Sec Filling | Patents | 480 employees

(US) National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.

add to watch list Paper trade email alert is off

Psychemedics Corporation

PMD | $2.655 5.54% 940

Health Services

(0.0% 1d) (-13.1% 1m) (-50.9% 1y) (0.0% 2d) (0.0% 3d) (4.3% 7d) (18.65% volume)
Earnings Calendar:
Market Cap: $ 15,413,897
http://www.psychemedics.com
Sec Filling | Patents | 204 employees

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

opioid

add to watch list Paper trade email alert is off

Quest Diagnostics Incorporated

DGX | News | $136.7 5.08% 0.0% 2.1M

Health Services

(0.0% 1d) (0.6% 1m) (-11.2% 1y) (0.0% 2d) (0.0% 3d) (1.3% 7d) (NaN% volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 15,181,364,085
http://www.questdiagnostics.com
Sec Filling | Patents | 47000 employees

(US) Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

clinical trials diagnostics information technology

add to watch list Paper trade email alert is off

IQVIA Holdings, Inc.

IQV | $238.62 3.15% 0.0% 1.1M

Health Services

(0.0% 1d) (-7.0% 1m) (14.0% 1y) (0.0% 2d) (0.0% 3d) (1.8% 7d) (-5.13% volume)
Earnings Calendar: 2023-11-01
Market Cap: $ 43,309,530,000
http://www.iqvia.com
Sec Filling | Patents | 67000 employees

IQVIA Holdings, Inc. operates as a biotechnology company. It engages in healthcare development in the provision of professional services, information technology, and partnering solutions. It operates through the following segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment provides mission critical information, technology solutions and real world solutions and services to the firm's life science clients. Research & Development Solutions segment, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

clinical trials msa information technology

add to watch list Paper trade email alert is off

Laboratory Corporation of America Holdings

LH M | $207.97 2.41% 0.0% 930K

Health Services

(0.0% 1d) (-5.0% 1m) (-12.7% 1y) (0.0% 2d) (0.0% 3d) (1.6% 7d) (-10.71% volume)
Earnings Calendar: 2024-02-15
Market Cap: $ 17,495,660,303
http://www.labcorp.com
Sec Filling | Patents | 65000 employees

(US) Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

genomic diagnostics

add to watch list Paper trade email alert is off

Protalix BioTherapeutics, Inc.

PLX | $1.2 1.7% 0.0% 270K

Health Services

(0.0% 1d) (-3.3% 1m) (-51.0% 1y) (0.0% 2d) (0.0% 3d) (2.6% 7d) (-49.96% volume)
Earnings Calendar:
Market Cap: $ 87,662,549
http://www.protalix.com
Sec Filling | Patents | 196 employees

(IL) Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.

israel t-cell ceiling

add to watch list Paper trade email alert is off